JPS53111083A - Method of producing 2*44diaminoo55benzyll pyrimidine derivative - Google Patents

Method of producing 2*44diaminoo55benzyll pyrimidine derivative

Info

Publication number
JPS53111083A
JPS53111083A JP15503777A JP15503777A JPS53111083A JP S53111083 A JPS53111083 A JP S53111083A JP 15503777 A JP15503777 A JP 15503777A JP 15503777 A JP15503777 A JP 15503777A JP S53111083 A JPS53111083 A JP S53111083A
Authority
JP
Japan
Prior art keywords
producing
pyrimidine derivative
pyrimidine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15503777A
Other languages
Japanese (ja)
Inventor
Roosu Baabara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS53111083A publication Critical patent/JPS53111083A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP15503777A 1971-04-16 1977-12-22 Method of producing 2*44diaminoo55benzyll pyrimidine derivative Pending JPS53111083A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB963971A GB1407971A (en) 1971-04-16 1971-04-16 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor

Publications (1)

Publication Number Publication Date
JPS53111083A true JPS53111083A (en) 1978-09-28

Family

ID=9875880

Family Applications (3)

Application Number Title Priority Date Filing Date
JP3763772A Pending JPS5320511B1 (en) 1971-04-16 1972-04-14
JP15503677A Granted JPS5430189A (en) 1971-04-16 1977-12-22 Production of 2*44diaminoo 55benzylpyrimidine derivative
JP15503777A Pending JPS53111083A (en) 1971-04-16 1977-12-22 Method of producing 2*44diaminoo55benzyll pyrimidine derivative

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP3763772A Pending JPS5320511B1 (en) 1971-04-16 1972-04-14
JP15503677A Granted JPS5430189A (en) 1971-04-16 1977-12-22 Production of 2*44diaminoo 55benzylpyrimidine derivative

Country Status (13)

Country Link
JP (3) JPS5320511B1 (en)
AU (1) AU468447B2 (en)
BE (1) BE782153A (en)
CA (1) CA967964A (en)
CH (1) CH565160A5 (en)
CS (1) CS181221B2 (en)
DE (1) DE2218220A1 (en)
DK (1) DK131466B (en)
FR (1) FR2133752B1 (en)
GB (1) GB1407971A (en)
IL (3) IL39218A (en)
NL (1) NL7205043A (en)
SE (1) SE391180B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738760B (en) * 1972-12-21 1974-08-28 Hoffmann La Roche Process for the manufacture of benzyl pyrimidines
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
FR2502152A1 (en) * 1981-03-20 1982-09-24 Panmedica Laboratoires NOVEL SUBSTITUTED DIAMINO-2,4-BENZYL-5-PYRIMIDINE N2-SOLUBLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING SAME

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1090394A (en) * 1953-03-11 1955-03-30 Wellcome Found Pyrimidine derivatives and their manufacture
FR1459417A (en) * 1964-11-12 1966-04-29 Hoffmann La Roche Process for the preparation of pyrimidine derivatives
FR1518635A (en) * 1965-07-08 1968-03-29 Wellcome Found Process for the preparation of pyrimidine derivatives
GB1261455A (en) * 1969-03-06 1972-01-26 Burroughs Wellcome Co Improvements in or relating to substituted acrylonitriles

Also Published As

Publication number Publication date
NL7205043A (en) 1972-10-18
SE391180B (en) 1977-02-07
CS181221B2 (en) 1978-03-31
JPS5320511B1 (en) 1978-06-27
IL47921A (en) 1976-10-31
JPS5430189A (en) 1979-03-06
DK131466B (en) 1975-07-21
IL39218A0 (en) 1972-06-28
JPS5422994B2 (en) 1979-08-10
CH565160A5 (en) 1975-08-15
AU4117472A (en) 1973-10-18
DK131466C (en) 1975-12-08
DE2218220A1 (en) 1972-11-02
AU468447B2 (en) 1976-01-15
CA967964A (en) 1975-05-20
FR2133752A1 (en) 1972-12-01
IL39218A (en) 1976-10-31
FR2133752B1 (en) 1975-04-25
BE782153A (en) 1972-10-16
IL47921A0 (en) 1975-11-25
GB1407971A (en) 1975-10-01

Similar Documents

Publication Publication Date Title
SU721000A3 (en) Method of producing acylaniline
CS188883B2 (en) Method of producing novel derivatives of penicillin
GB1395551A (en) Method of producing polyesters
JPS53135991A (en) Method of producing 2*44diaminoo55 benzylpyrimidine
JPS5373568A (en) Method of producing pyridine compounds
CS183654B2 (en) Method of producing 3-methylencephalosporines
JPS53130675A (en) Method of producing pyridine derivative
CS194170B2 (en) Method of producing 5-fluor-2-methyl-1-/4'-methyl-sulphinylbenzyliden/-3-indenylacetic acid
CS191160B2 (en) Method of producing derivatives of quinazoline
GB1400783A (en) Method of producing polyhydric compounds
CS180585B2 (en) Method of producing derivatives of 2-nitro-5-vinylimidazole
JPS5387342A (en) Method for production of new 44*44biphenyl**11butanol
CS191204B2 (en) Method of producing bicyclic derivatives of pyrimidine
CS183671B2 (en) Method of producing pure e-caprolactame
JPS53116386A (en) Method of producing novel hydroxypyrimidines
GB1320984A (en) Method of producing 1,3-bis-hydroxyaryl tetraorganodisolaxanes
CS181207B2 (en) Method of producing benzocycloheptaisochinoline derivatives
CS185564B2 (en) Method of producing new alpha -3-acylureidomethylpenicilines
JPS53111083A (en) Method of producing 2*44diaminoo55benzyll pyrimidine derivative
CS180580B2 (en) Method of producing new derivatives of 2-formyl-3-carboxamidochinoxalin-di-n-oxides
JPS53127486A (en) Method of producing quinoxalinee1*44dioxide
CS184313B2 (en) Method of producing alkyl-7-deoxy-7-rs-alpha-thiolincosaminides
JPS5387361A (en) Method of producing 22*22aminobenzoyl*pyridine
IL39028A0 (en) Method of producing n-trihalogenoalkylthio derivatives
CS181271B2 (en) Method of producing 17 beta-oxalylsteroids